发明名称 Ингибиторы интегрина αvβ6
摘要 Peptide compound (I), is new. New peptide has formula (I): W1>-X1>N-Arg-X2>-Asp-Leu-X3>-X4>-Leu-X5>-X6>m-W2> (I); X1>-X6>amino acid residue chosen from Ala, Asn, Asp, Arg, Cys, Gln, Glu, Gly, Phe, His, Ile, Leu, Lys, Met, Nle, homo-Phe, Phg, Pro, Ser, Thr, Trp, Tyr or Val, and known amino acid derivatives; Nle : norleucine; Phg : phenylglycine; W1>H or Ac; W2>OH, OR, NHR, NR2, NH2; R : 1-6C alkyl; and n, m : 0 - 15. ACTIVITY : Cardiant; thrombolytic; cytostatic; osteopathic; antiinflammatory; antipsoriatic; antiarteriosclerotic. MECHANISM OF ACTION : alpha vbeta 6 Integrin Receptor Inhibitor.
申请公布号 RU2002124494(A) 申请公布日期 2004.01.10
申请号 RU20020124494 申请日期 1999.12.11
申请人 МЕРК ПАТЕНТ ГМБХ (DE) 发明人 ДИФФЕНБАХ Беате (DE);ЙОНЧИК Альфред (DE);КРАФТ Забине (DE);МЕНТА Рей (GB)
分类号 C07K7/06;A61K35/76;A61K38/00;A61K38/04;A61P1/04;A61P3/10;A61P7/02;A61P9/10;A61P13/12;A61P17/02;A61P17/06;A61P19/02;A61P19/10;A61P27/02;A61P27/06;A61P29/00;A61P31/00;A61P35/00;A61P37/08;A61P43/00;C07K7/08;C12N7/00;C12N15/09;C12N15/10 主分类号 C07K7/06
代理机构 代理人
主权项
地址